$15.91
1.60% today
Nasdaq, Sep 11, 04:48 pm CET
ISIN
US8257041090
Symbol
SIBN

SI-BONE, Inc. Stock price

$15.66
+0.26 1.69% 1M
+0.24 1.52% 6M
+1.64 11.70% YTD
-0.02 0.13% 1Y
-2.40 13.29% 3Y
-6.06 27.90% 5Y
-4.40 21.93% 10Y
-4.40 21.93% 20Y
Nasdaq, Closing price Wed, Sep 10 2025
-0.38 2.37%

Key metrics

Basic
Market capitalization
$675.6m
Enterprise Value
$565.6m
Net debt
positive
Cash
$145.5m
Shares outstanding
43.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
3.6 | 3.4
EV/Sales
3.1 | 2.8
EV/FCF
negative
P/B
4.0
Financial Health
Equity Ratio
72.5%
Return on Equity
-18.5%
ROCE
-13.4%
ROIC
-35.9%
Debt/Equity
0.2
Financials (TTM | estimate)
Revenue
$185.3m | $200.5m
EBITDA
$-22.7m | $-262.3k
EBIT
$-27.6m | $-29.2m
Net Income
$-23.8m | $-26.2m
Free Cash Flow
$-12.7m
Growth (TTM | estimate)
Revenue
22.9% | 19.9%
EBITDA
44.2% | 99.2%
EBIT
39.7% | 17.1%
Net Income
41.8% | 15.4%
Free Cash Flow
51.0%
Margin (TTM | estimate)
Gross
79.5%
EBITDA
-12.2% | -0.1%
EBIT
-14.9%
Net
-12.8% | -13.0%
Free Cash Flow
-6.9%
More
EPS
$-0.6
FCF per Share
$-0.3
Short interest
4.9%
Employees
349
Rev per Employee
$480.0k
Show more

Is SI-BONE, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,008 stocks worldwide.

SI-BONE, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

14x Buy
93%
1x Hold
7%

Analyst Opinions

15 Analysts have issued a SI-BONE, Inc. forecast:

Buy
93%
Hold
7%

Financial data from SI-BONE, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
185 185
23% 23%
100%
- Direct Costs 38 38
13% 13%
21%
147 147
26% 26%
79%
- Selling and Administrative Expenses 158 158
8% 8%
85%
- Research and Development Expense 17 17
0% 0%
9%
-23 -23
44% 44%
-12%
- Depreciation and Amortization 4.94 4.94
5% 5%
3%
EBIT (Operating Income) EBIT -28 -28
40% 40%
-15%
Net Profit -24 -24
42% 42%
-13%

In millions USD.

Don't miss a Thing! We will send you all news about SI-BONE, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

SI-BONE, Inc. Stock News

Neutral
Seeking Alpha
2 days ago
SI-BONE, Inc. (NASDAQ:SIBN ) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:00 AM EDT Company Participants Laura Francis - CEO & Director Anshul Maheshwari - Chief Financial Officer Presentation Unknown Analyst All right. Good morning.
Neutral
GlobeNewsWire
16 days ago
SANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. Management will be hosting a fireside chat on Tuesday, September 9, 2025, at 4:00 a.m. Pacific Time...
Positive
The Motley Fool
about one month ago
Si-bone (SIBN 2.93%), a medical device innovator focused on minimally invasive surgery for joint dysfunction and pelvic conditions, released its second quarter 2025 results on August 4, 2025. The company reported GAAP revenue of $48.6 million and a GAAP net loss per share of $(0.14) for Q2 2025.
More SI-BONE, Inc. News

Company Profile

SI-BONE, Inc. is a medical device company. It focuses on the development of implantable devices used in the surgical treatment of the sacropelvic anatomy. The firm's product, iFuse, seeks to fuse the sacroiliac joint to treat sacroiliac joint dysfunction that often causes severe lower back pain. The company was founded by Mark A. Reiley and Jeffrey W. Dunn on March 18, 2008 and is headquartered in San Jose, CA.

Head office United States
CEO Laura Francis
Employees 349
Founded 2008
Website si-bone.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today